Novo Nordisk’s weight-loss drug Wegovy has been surpassed in weekly U.S. prescriptions by Eli Lilly’s Zepbound, and now the ...

A new study suggests that urban environments may influence how impulsivity disorders like ADHD contribute to the obesity ...

The data showed that kids who don’t see their BMI decline between ages 1 and 6 have a greater risk of obesity. This risk was ...

Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...

By Dennis Thompson HealthDay ReporterWEDNESDAY, May 28, 2025 (HealthDay News) — Popular GLP-1 weight loss drugs like Ozempic ...

Metabolic-associated fatty liver disease is prevalent in children and adolescents with severe obesity, with higher insulin ...

Adopting a healthy lifestyle that includes plenty of physical activity and a low fat diet is a necessary step when waging the ...

Viking Therapeutics faces tough obesity drug rivals, with VK2735 showing promise but an uncertain edge. Find out why VKTX ...

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

Turkey has launched a nationwide campaign to measure citizens’ weight in public to combat its rising obesity rates — a move ...